TherapeuticsMD Inc TXMD shares are surging Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.
EW Healthcare Partners will commence a tender offer to acquire all outstanding shares of TherapeuticsMD common stock for $10 per share in an all-cash transaction, which will be followed immediately by a merger under the terms of the transaction. The transaction implies a total enterprise value of approximately $177 million.
Upon completion of the transaction, TherapeuticsMD will become a privately held company. The transaction is expected to be completed on or before July 13.
TherapeuticsMD is a drug manufacturer with a focus on creating and commercializing products designed exclusively for women.
See Also: Why MoonLake Immunotherapeutics Shares Are Surging Higher Today
TXMD Price Action: TherapeuticsMD has traded between 15 cents and $6.55 over a 52-week period.
The stock was up 343.2% at $9.49 at press time, according to data from Benzinga Pro.
Photo: StockSnap from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
